May 2012 $2 M No. 6 Under $2 million 8
HyperBranch Medical Technology Inc: Raise no. 6, May 2012 × Investors in this round 8 investors had bought by the notice of Nov 28, 2012: 8 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $4 M offered; $2 M still to sell
Smallest investment taken $1,368
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $700,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Jeffrey G Clark · Executive Officer John Conn · Executive Officer, Director Aaron Jefferson Davidson · Director B. Jefferson Clark · Director Chris Jefferson Kroeger · Director Michael Jefferson Wasserman · Director Robert White · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by John Conn, President and CEO. Source: SEC Form D and 1 amendment, newest notice filed Nov 28, 2012. Read the notice at the SEC .
equity SEC Oct 2011 $1 M No. 5 Under $2 million 7
HyperBranch Medical Technology Inc: Raise no. 5, Oct 2011 × Investors in this round 7 investors had bought by the notice of Oct 20, 2011: 7 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $250,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Jeffrey G Clark · Executive Officer John Conn · Executive Officer, Director Aaron Jefferson Davidson · Director B. Jefferson Clark · Director Chris Jefferson Kroeger · Director Michael Jefferson Wasserman · Director Robert White · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by John Conn, President and CEO. Source: SEC Form D, newest notice filed Oct 20, 2011. Read the notice at the SEC .
equity SEC Nov 2010 $2 M No. 4 $2 to $10 million 7
HyperBranch Medical Technology Inc: Raise no. 4, Nov 2010 × Investors in this round 7 investors had bought by the notice of Nov 22, 2010: 7 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice John Conn · Executive Officer, Director Aaron Jefferson Davidson · Director B. Jefferson Clark · Director Bob JEFFERSON White · Director Chris Jefferson Kroeger · Director Michael Jefferson Wasserman · Director Robert V. Toni · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by John Conn, President & CEO. Source: SEC Form D, newest notice filed Nov 22, 2010. Read the notice at the SEC .
equity SEC Apr 2010 $2 M No. 3 $2 to $10 million 7
HyperBranch Medical Technology Inc: Raise no. 3, Apr 2010 × Investors in this round 7 investors had bought by the notice of Apr 19, 2010: 7 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken $1
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice John Conn · Executive Officer, Director Aaron Jefferson Davidson · Director B. Jefferson Clark · Director Chris Jefferson Kroeger · Director Michael Jefferson Wasserman · Director Robert V. Toni · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by William N. Wofford, Assistant Secretary. Source: SEC Form D, newest notice filed Apr 19, 2010. Read the notice at the SEC .
equity SEC Apr 2009 $1 M No. 2 Under $2 million 3
HyperBranch Medical Technology Inc: Raise no. 2, Apr 2009 × Investors in this round 3 investors had bought by the notice of May 12, 2009: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken $1
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in De People named in the notice John Conn · Executive Officer, Director Aaron Davidson · Director B. Jefferson Clark · Director Chris Kroeger · Director Michael Wasserman · Director Robert V. Toni · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by J. Robert Tyler, III, Assistant Secretary. Source: SEC Form D, newest notice filed May 12, 2009. Read the notice at the SEC .
equity SEC Jan 2009 $2 M No. 1 Under $2 million 3
HyperBranch Medical Technology Inc: Raise no. 1, Jan 2009 × Investors in this round 3 investors had bought by the notice of Feb 25, 2009: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken $1
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in De People named in the notice John Conn · Executive Officer, Director Aaron Davidson · Director B. Jefferson Clark · Director Chris Kroeger · Director Michael Wasserman · Director Robert V. Toni · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by J. Robert Tyler, III, Assistant Secretary. Source: SEC Form D, newest notice filed Feb 25, 2009. Read the notice at the SEC .
equity SEC